227 related articles for article (PubMed ID: 11788928)
1. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
2. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
4. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
6. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
7. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.
Strauss R; Wehler M; Mehler K; Kreutzer D; Koebnick C; Hahn EG
Crit Care Med; 2002 Aug; 30(8):1765-71. PubMed ID: 12163790
[TBL] [Abstract][Full Text] [Related]
9. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
11. Acute bleeding and thrombocytopenia after bone marrow transplantation.
Nevo S; Enger C; Hartley E; Borinsky ME; Swan V; Fuller AK; Braine HG; Kickler TS; George JN; Vogelsang GB
Bone Marrow Transplant; 2001 Jan; 27(1):65-72. PubMed ID: 11244439
[TBL] [Abstract][Full Text] [Related]
12. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
[TBL] [Abstract][Full Text] [Related]
13. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
[TBL] [Abstract][Full Text] [Related]
14. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic platelet transfusion in acute leukemia: which threshold should be used.
Finazzi G
Haematologica; 1998 Nov; 83(11):961-2. PubMed ID: 9864912
[No Abstract] [Full Text] [Related]
16. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
17. Impact of Preoperative Platelet Count on Bleeding Risk and Allogeneic Transfusion in Multilevel Spine Surgery.
Chow JH; Chancer Z; Mazzeffi MA; McNeil JS; Sokolow MJ; Gaines TM; Reif MM; Trinh AT; Wellington IJ; Camacho JE; Bruckner JJ; Tanaka KA; Ludwig S
Spine (Phila Pa 1976); 2021 Jan; 46(1):E65-E72. PubMed ID: 33306659
[TBL] [Abstract][Full Text] [Related]
18. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.
Batman B; van Bladel ER; van Hamersveld M; Pasker-de Jong PCM; Korporaal SJA; Urbanus RT; Roest M; Boven LA; Fijnheer R
Vox Sang; 2017 Nov; 112(8):773-779. PubMed ID: 28960383
[TBL] [Abstract][Full Text] [Related]
20. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
